Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,508,012
-
Share change
-
+3,289,658
-
Total reported value
-
$5,069,303,978
-
Put/Call ratio
-
38%
-
Price per share
-
$125.20
-
Number of holders
-
287
-
Value change
-
+$424,292,855
-
Number of buys
-
146
-
Number of sells
-
135
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q1 2017
As of 31 Mar 2017,
ABIOMED INC - COMMON STOCK (ABMD) was held by
287 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,508,012 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Palo Alto Investors, LLC, BAILLIE GIFFORD & CO, Essex Woodlands Health Ventures, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
287
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.